ERBB2 and breast carcinoma: <b>Conclusions:</b> V-125 but not bexarotene reprograms tumor transcriptional programs and the immune landscape in an anti-tumor manner in the MMTV-neu mouse model and in in vitro models of HER2<sup>+</sup> breast cancer.